beta Amyloid Antikörper (AA 1-42)
Kurzübersicht für beta Amyloid Antikörper (AA 1-42) (ABIN2477631)
Target
Alle beta Amyloid (Abeta) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-42
-
Produktmerkmale
- Serum
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
-
-
Amyloid angiopathy in idiopathic Parkinson's disease. Immunohistochemical and ultrastructural study." in: Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences, Vol. 46, Issue 4, pp. 255-70, (2009) (PubMed).
: "Intracranial administration of deglycosylated C-terminal-specific anti-Abeta antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice." in: Journal of neuroinflammation, Vol. 3, pp. 11, (2006) (PubMed).
: "
-
Amyloid angiopathy in idiopathic Parkinson's disease. Immunohistochemical and ultrastructural study." in: Folia neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences, Vol. 46, Issue 4, pp. 255-70, (2009) (PubMed).
-
- beta Amyloid (Abeta) (Amyloid beta (Abeta))
-
Andere Bezeichnung
- beta AMYLOID
-
Gen-ID
- 351
-
UniProt
- P05067
-
Pathways
- Inflammasome
Target
-